Fosaprepitant

NDC 0591-4385 · Actavis Pharma, Inc.

Generic namefosaprepitant

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)FOSAPREPITANT DIMEGLUMINE

Strength150 mg/1

Pharmacologic classCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Marketing categoryNDA

Packages

0591-4385-79 — 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)

Billed under HCPCS

J1456 — Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg Medicare Part B payment limit (ASP + 6%): $0.04

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0006-3061 — FOSAPREPITANT DIMEGLUMINE, 0143-9384 — FOSAPREPITANT DIMEGLUMINE, 0143-9428 — FOSAPREPITANT DIMEGLUMINE, 0338-0008 — Fosaprepitant Dimeglumine, 16714-248 — Fosaprepitant dimeglumine, 31722-165 — Fosaprepitant dimeglumine, 43598-671 — Fosaprepitant, 43598-859 — Fosaprepitant, 43598-948 — Fosaprepitant, 55150-299 — FOSAPREPITANT DIMEGLUMINE, 63323-972 — FOSAPREPITANT, 67184-0540 — FOSAPREPITANT DIMEGLUMINE, 67457-889 — fosaprepitant, 68001-421 — Fosaprepitant, 68001-523 — Fosaprepitant dimeglumine, 68001-675 — Fosaprepitant, 70121-2631 — FOSAPREPITANT DIMEGLUMINE, 71731-5111 — FOSAPREPITANT DIMEGLUMINE, 71839-104 — fosaprepitant, 72162-2636 — Fosaprepitant, +6 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.